multiple&#45

A Bioequivalence study of a randomized, open-labeled, multiple-dose, two-way crossover design with two-period, two-treatment, two-sequence steady-state bioequivalence study of Alfuzosin Prolonged-Release Tablet (10 mg) relative to Xatral® XL 10 mg in healthy Thai male volunteers under fed conditions and at least 9 days washout period between the doses

A Bioequivalence study of a randomized, open-labeled, multiple-dose, fully replicate crossover design with two-period, two-treatment, two-sequence with two consecutive days of profiling at steady-state bioequivalence study of Alfuzosin Prolonged-Release Tablet (10 mg) relative to Xatral (R) XL 10 mg in healthy Thai male volunteers under fed conditions and at least 8 days washout period between the doses